DrugCite
Search

NO TREATMENT RECEIVED NOMED

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

No Treatment Received Nomed Adverse Events Reported to the FDA Over Time

How are No Treatment Received Nomed adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for No Treatment Received Nomed, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if No Treatment Received Nomed is flagged as the suspect drug causing the adverse event.

Most Common No Treatment Received Nomed Adverse Events Reported to the FDA

What are the most common No Treatment Received Nomed adverse events reported to the FDA?

Dyspnoea
168 (2.69%)
Pyrexia
117 (1.87%)
Cardiac Failure
103 (1.65%)
Disease Progression
102 (1.63%)
Hypotension
93 (1.49%)
Blood Creatinine Increased
77 (1.23%)
Dizziness
75 (1.2%)
Vomiting
74 (1.18%)
Asthenia
68 (1.09%)
Decreased Appetite
66 (1.06%)
Diarrhoea
65 (1.04%)
Show More Show More
Pneumonia
65 (1.04%)
Abdominal Pain
60 (.96%)
Nausea
60 (.96%)
Renal Failure Acute
54 (.86%)
Cough
53 (.85%)
Malaise
49 (.78%)
Renal Impairment
49 (.78%)
Dehydration
48 (.77%)
Chest Pain
45 (.72%)
Sepsis
45 (.72%)
Concomitant Disease Progression
43 (.69%)
Pleural Effusion
42 (.67%)
Fall
41 (.66%)
Oedema Peripheral
38 (.61%)
Atrial Fibrillation
37 (.59%)
Fatigue
37 (.59%)
Lymphocele
37 (.59%)
Renal Failure
37 (.59%)
Angina Pectoris
36 (.58%)
Malignant Neoplasm Progression
36 (.58%)
Hyperkalaemia
35 (.56%)
Anaemia
34 (.54%)
Urinary Tract Infection
34 (.54%)
Drug Ineffective
33 (.53%)
Chills
32 (.51%)
Headache
31 (.5%)
Hypertension
30 (.48%)
Dyspnoea Exertional
29 (.46%)
Surgery
27 (.43%)
Syncope
27 (.43%)
Oedema
26 (.42%)
Coronary Artery Disease
25 (.4%)
Pain
24 (.38%)
Productive Cough
23 (.37%)
Confusional State
22 (.35%)
Orthopnoea
22 (.35%)
Seroma
22 (.35%)
Cardiac Failure Congestive
21 (.34%)
Myocardial Infarction
21 (.34%)
Blood Glucose Increased
20 (.32%)
Leukopenia
20 (.32%)
Staphylococcal Infection
20 (.32%)
C-reactive Protein Increased
19 (.3%)
Cardiomegaly
19 (.3%)
Multi-organ Failure
19 (.3%)
Gastric Ulcer
18 (.29%)
Gastritis
18 (.29%)
General Physical Health Deteriorati...
18 (.29%)
Loss Of Consciousness
18 (.29%)
Rales
18 (.29%)
Acute Coronary Syndrome
17 (.27%)
Catheterisation Cardiac
17 (.27%)
Cholangitis
17 (.27%)
Impaired Healing
17 (.27%)
Proteinuria
17 (.27%)
Pulmonary Oedema
17 (.27%)
Septic Shock
17 (.27%)
Blood Urea Increased
16 (.26%)
Complications Of Transplanted Kidne...
16 (.26%)
Cytomegalovirus Infection
16 (.26%)
Hyperglycaemia
16 (.26%)
Hypokalaemia
16 (.26%)
Inflammation
16 (.26%)
Nephropathy Toxic
16 (.26%)
Respiratory Failure
16 (.26%)
Tachycardia
16 (.26%)
Abdominal Distension
15 (.24%)
Chest Discomfort
15 (.24%)
Death
15 (.24%)
Lung Infiltration
15 (.24%)
Nephrectomy
15 (.24%)
Renal Cyst
15 (.24%)
White Blood Cell Count Increased
15 (.24%)
Blood Potassium Decreased
14 (.22%)
Chronic Obstructive Pulmonary Disea...
14 (.22%)
Condition Aggravated
14 (.22%)
Convulsion
14 (.22%)
Depressed Level Of Consciousness
14 (.22%)
Dyspnoea At Rest
14 (.22%)
Gastroenteritis
14 (.22%)
Gastrointestinal Haemorrhage
14 (.22%)
Kidney Transplant Rejection
14 (.22%)
Vertigo
14 (.22%)
Weight Decreased
14 (.22%)
Alanine Aminotransferase Increased
13 (.21%)
Diabetes Mellitus
13 (.21%)
Erythema
13 (.21%)
Escherichia Infection
13 (.21%)
Gastritis Erosive
13 (.21%)
Heart Rate Decreased
13 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for No Treatment Received Nomed, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if No Treatment Received Nomed is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for No Treatment Received Nomed

What are the most common No Treatment Received Nomed adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for No Treatment Received Nomed, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if No Treatment Received Nomed is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of No Treatment Received Nomed According to Those Reporting Adverse Events

Why are people taking No Treatment Received Nomed, according to those reporting adverse events to the FDA?

Renal Transplant
156
Cardiac Failure
131
Carcinoid Tumour
70
Dementia Alzheimers Type
39
Pancreatic Neuroendocrine Tumour
37
Liver Transplant
36
Show More Show More
Glucose Tolerance Impaired
31
Cardiac Failure Chronic
24
Hypertension
15
Cardiovascular Disorder
14
Type 2 Diabetes Mellitus
13
Chronic Obstructive Pulmonary Disea...
11
Gout
11
Hepatic Neoplasm Malignant
10
Coronary Artery Disease
10
Osteoporosis
9
Breast Cancer
8
Juvenile Arthritis
8
Heart Transplant
8
Multiple Sclerosis
7
Breast Cancer Metastatic
6
Metastases To Bone
5
Gastric Cancer
5
Dermatitis Atopic
4
Chronic Graft Versus Host Disease
4
Osteoporosis Postmenopausal
4
Cardiac Failure Acute
3
Essential Hypertension
3
Nephropathy
2
Organ Transplant
2
Cystic Fibrosis
2
Multiple Myeloma
2
Neuroendocrine Tumour
2
Acute Coronary Syndrome
2
Renal Cancer Metastatic
2
Partial Seizures
2
Metastatic Renal Cell Carcinoma
1
Acute Myocardial Infarction
1
Metastatic Gastric Cancer
1
Acute Lymphocytic Leukaemia
1
Meningitis Cryptococcal
1
Immunosuppression
1
Lung Transplant
1
Pulmonary Arterial Hypertension
1
Hepatitis B
1
Non-small Cell Lung Cancer
1
Behcets Syndrome
1
Diabetes Mellitus
1
Prostate Cancer
1

No Treatment Received Nomed Case Reports

What No Treatment Received Nomed safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for No Treatment Received Nomed. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with No Treatment Received Nomed.